InvestorsHub Logo
Followers 41
Posts 6404
Boards Moderated 1
Alias Born 04/10/2012

Re: Destiny Defined post# 388214

Sunday, 09/24/2023 12:57:06 PM

Sunday, September 24, 2023 12:57:06 PM

Post# of 414279
Yep the “worst case” scenarios here regarding Vyvanse still have us sitting pretty.

This is excluding Oxy and if Concerta is indeed the 3rd needle mover product.

Add the 2 smaller drugs we should get approval for within the next 4 months or so.

Vigabatrin with Pyros.

Prasco/Burel on Jan 1.

Dexcel wildcard.

Whatever else we don’t know about yet in earlier pipeline stages.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News